Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.85B | $ 588.00M | $ 1.29B | $ 765.00M | $ 1.63B |
Total Assets | $ 30.96B | $ 28.11B | $ 29.09B | $ 29.13B | $ 32.31B |
Total Debt | $ 10.26B | $ 9.94B | $ 10.07B | $ 11.26B | $ 11.95B |
Net Debt | $ 8.40B | $ 9.35B | $ 8.79B | $ 10.49B | $ 10.32B |
Total Liabilities | $ 23.48B | $ 22.22B | $ 23.15B | $ 24.10B | $ 26.79B |
Stockholders Equity | $ 6.86B | $ 5.33B | $ 5.35B | $ 4.45B | $ 4.87B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |